Malignant Hepatobiliary Neoplasm — Trials

Malignant Hepatobiliary Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

5,022 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,157
Recruiting: 665
Ph III recruiting: 61
Growth YoY: +7.9%
Industry share: 22%
Top sponsor: Sun Yat-sen University
Termination share: 32.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (560)

clinicaltrialsPublishedShowing 1–5 of 5 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02853500	Effect of Surefire Infusion Device on Tumor Response to Regional Intra-arterial Therapy for Primary Liver Malignancies	withdrawn	Phase 4	0	Dana-Farber Cancer InstituteOTHER	1	Feb 5, 2025	clinicaltrials
NCT02174575	Anesthetic Agents and Acute Kidney Injury After Liver Resection Surgery	withdrawn	Phase 4	0	Tokyo Medical and Dental UniversityOTHER	1	May 3, 2023	clinicaltrials